semaglutide constipation lawsuit in dallas FDA warns Ozempic and Wegovy maker over unreported GLP-1 side effects Weight Loss Drug - Ozempic

Understanding these changes helps you track your health progress and ensures your prescriber has complete information for dose adjustments

For this patient who has achieved significant weight loss on Wegovy but must discontinue it, the most critical strategy is intensive lifestyle intervention c...

Today, drugs like Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) are being prescribed and demanded for obesity

Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial

A subgroup of patients using the GLP-1 tirzepatide experience nearly twice the improvement in sleep apnea severity.

Although the FDA said the Wegovy shortage was over, learn why it happened and what to do it if happens again.